Choate Investment Advisors’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,128
| Closed | -$62K | – | 360 |
|
|
2023
Q1 | $62K | Hold |
5,128
| – | – | ﹤0.01% | 289 |
|
|
2022
Q4 | $23.3K | Hold |
5,128
| – | – | ﹤0.01% | 317 |
|
|
2022
Q3 | $34K | Hold |
5,128
| – | – | ﹤0.01% | 278 |
|
|
2022
Q2 | $55K | Hold |
5,128
| – | – | ﹤0.01% | 288 |
|
|
2022
Q1 | $98K | Hold |
5,128
| – | – | 0.01% | 309 |
|
|
2021
Q4 | $184K | Hold |
5,128
| – | – | 0.01% | 282 |
|
|
2021
Q3 | $377K | Buy |
+5,128
| New | +$377K | 0.02% | 198 |
|